Evidence-based safety information about medication, vaccine, chemical and radiological exposures in pregnancy - UKTIS logo
  • Home
  • UKTIS
    • About Us
    • Meet the team
  • Resources
    • Information for healthcare providers
    • Information for pregnant women
    • UKTIS Response Statements
    • Presentations
    • News Archive
    • Promotional material
    • Links
  • Surveillance
    • Patient confidentiality
    • Data collection
    • Reporting an exposure
    • COVID-19 Antivirals pregnancy registry
  • Research
    • Current and past projects
    • Scientific publications
  • Contact
  • Login
  • Account

UKTIS Response Statements

Here you can find our official response statements to common enquiries, please select your query from the list below:

Paracetamol in pregnancy and Autism Spectrum Disorder (September 2025)

High-dose folic acid use in women with epilepsy in pregnancy childhood cancer risk (March 2023)

Librium (chlordiazepoxide) SPC updates (May 2022)

Tocilizumab shortage (September 2021)

Ondansetron and the risk of oral cleft anomalies (September 2019)

Help and advice

Healthcare professionals can contact UKTIS on 0344 892 0909 between 09:00-17:00 Mon-Fri (excluding bank holidays) for routine enquiries.  Urgent enquiries are answered 24 hours per day, seven days per week.

Members of the public can visit www.medicinesinpregnancy.org to access information. Or ask your GP or other health care professional to telephone UKTIS on your behalf, for up-to-date advice.

The UKTIS office (0191 213 7880) is open between 09:00-17:00 Monday-Friday (excluding bank holidays) for administration enquiries only.  No health care or pregnancy related advice is provided on this number.

Commissioned by

© UKTIS.

  • Privacy Policy
  • Cookie Policy
  • Copyright Notice
  • Terms and Conditions
  • Site Disclaimer